KM plots demonstrated that women diagnosed with ER+/PR+ breast cancers whose tumor also expressed high levels of leptin (n = 25) demonstrated poorer prognosis with increased mortality rates as compared to ER+/PR+ breast cancers with lower levels of leptin (n = 73; P = 0.038; Figure 6A). Here, LEP is linked to breast cancer.